{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:49:05Z","timestamp":1787590145440,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Orthop Trauma Surg"],"DOI":"10.1007\/s00402-025-05852-6","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:45:31Z","timestamp":1744875931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Survival impact of pathological fractures in metastatic cancer: a comprehensive meta-analysis"],"prefix":"10.1007","volume":"145","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Lamo-Espinosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Mariscal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"G\u00f3mez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"San-Juli\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"5852_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.lungcan.2014.08.022","volume":"86","author":"K Cetin","year":"2014","unstructured":"Cetin K, Christiansen CF, Jacobsen JB, N\u00f8rgaard M, S\u00f8rensen HT (2014) Bone metastasis, skeletal-related events, and mortality in lung cancer patients: A Danish population-based cohort study. Lung Cancer 86:247\u2013254. https:\/\/doi.org\/10.1016\/j.lungcan.2014.08.022","journal-title":"Lung Cancer"},{"key":"5852_CR2","doi-asserted-by":"publisher","first-page":"22205","DOI":"10.1038\/srep22205","volume":"6","author":"D Santini","year":"2016","unstructured":"Santini D, Barni S, Intagliata S, Falcone A, Ferra\u00f9 F, Galetta D et al (2016) Corrigendum: natural history of Non-Small-Cell lung cancer with bone metastases. Sci Rep 6:22205. https:\/\/doi.org\/10.1038\/srep22205","journal-title":"Sci Rep"},{"key":"5852_CR3","doi-asserted-by":"publisher","first-page":"100513","DOI":"10.1016\/j.jtocrr.2023.100513","volume":"4","author":"AJWM Brouns","year":"2023","unstructured":"Brouns AJWM, van Veelen A, Veerman GDM, Steendam C, Dursun S, van der Leest C et al (2023) Incidence of bone metastases and Skeletal-Related events in patients with EGFR-Mutated NSCLC treated with osimertinib. JTO Clin Res Rep 4:100513. https:\/\/doi.org\/10.1016\/j.jtocrr.2023.100513","journal-title":"JTO Clin Res Rep"},{"key":"5852_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","volume":"129","author":"M Yong","year":"2011","unstructured":"Yong M, Jensen A\u00d8, Jacobsen JB, N\u00f8rgaard M, Fryzek JP, S\u00f8rensen HT (2011) Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999\u20132007). Breast Cancer Res Treat 129:495\u2013503. https:\/\/doi.org\/10.1007\/s10549-011-1475-5","journal-title":"Breast Cancer Res Treat"},{"key":"5852_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1634\/theoncologist.2015-0327","volume":"21","author":"JA McDougall","year":"2016","unstructured":"McDougall JA, Bansal A, Goulart BHL, McCune JS, Karnopp A, Fedorenko C et al (2016) The clinical and economic impacts of Skeletal-Related events among medicare enrollees with prostate cancer metastatic to bone. Oncologist 21:320\u2013326. https:\/\/doi.org\/10.1634\/theoncologist.2015-0327","journal-title":"Oncologist"},{"key":"5852_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00520-006-0203-x","volume":"15","author":"V DePuy","year":"2007","unstructured":"DePuy V, Anstrom KJ, Castel LD, Schulman KA, Weinfurt KP, Saad F (2007) Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer 15:869\u2013876. https:\/\/doi.org\/10.1007\/s00520-006-0203-x","journal-title":"Support Care Cancer"},{"key":"5852_CR7","doi-asserted-by":"publisher","unstructured":"LiBrizzi CL, Vankara A, Meyer CF, Levin AS, Morris CD Bone metastases in patients with leiomyosarcoma: A retrospective analysis of survival and surgical management. Sarcoma 2022;2022:6806932. https:\/\/doi.org\/10.1155\/2022\/6806932","DOI":"10.1155\/2022\/6806932"},{"key":"5852_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/0970-2113.106127","volume":"30","author":"N Sathiakumar","year":"2013","unstructured":"Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V et al (2013) Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999\u20132006. Lung India 30:20\u201326. https:\/\/doi.org\/10.4103\/0970-2113.106127","journal-title":"Lung India"},{"key":"5852_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.critrevonc.2005.03.011","volume":"56","author":"G Selvaggi","year":"2005","unstructured":"Selvaggi G, Scagliotti GV (2005) Management of bone metastases in cancer: A review. Crit Rev Oncol Hematol 56:365\u2013378. https:\/\/doi.org\/10.1016\/j.critrevonc.2005.03.011","journal-title":"Crit Rev Oncol Hematol"},{"key":"5852_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10147-016-1075-9","volume":"22","author":"Y Tsuda","year":"2017","unstructured":"Tsuda Y, Nakagawa T, Shinoda Y, Kanatani A, Kawai T, Taguchi S et al (2017) Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis. Int J Clin Oncol 22:548\u2013553. https:\/\/doi.org\/10.1007\/s10147-016-1075-9","journal-title":"Int J Clin Oncol"},{"key":"5852_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71\u2013n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"5852_CR12","doi-asserted-by":"crossref","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg N D;73:712\u2013716","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"key":"5852_CR13","unstructured":"Higgins JP, Thomas J, Chandler J Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; n.d"},{"key":"5852_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jgo.2014.03.002","volume":"5","author":"E Onukwugha","year":"2014","unstructured":"Onukwugha E, Yong C, Mullins CD, Seal B, McNally D, Hussain A (2014) Skeletal-related events and mortality among older men with advanced prostate cancer. J Geriatr Oncol 5:281\u2013289. https:\/\/doi.org\/10.1016\/j.jgo.2014.03.002","journal-title":"J Geriatr Oncol"},{"key":"5852_CR15","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.jbo.2022.100427","volume":"34","author":"T Raschka","year":"2022","unstructured":"Raschka T, Weiss S, Reiter A, Barg A, Schlickewei C, Frosch K-H et al (2022) Outcomes and prognostic factors after surgery for bone metastases in the extremities and pelvis: A retrospective analysis of 140 patients. J Bone Oncol 34:100427. https:\/\/doi.org\/10.1016\/j.jbo.2022.100427","journal-title":"J Bone Oncol"},{"key":"5852_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrclinonc.2014.70","volume":"11","author":"BA Gartrell","year":"2014","unstructured":"Gartrell BA, Saad F (2014) Managing bone metastases and reducing skeletal related events in prostate cancer. Nat Rev Clin Oncol 11:335\u2013345. https:\/\/doi.org\/10.1038\/nrclinonc.2014.70","journal-title":"Nat Rev Clin Oncol"},{"key":"5852_CR17","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/cncr.22991","volume":"110","author":"F Saad","year":"2007","unstructured":"Saad F, Lipton A, Cook R, Chen Y, Smith M, Coleman R (2007) Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 110:1860\u20131867. https:\/\/doi.org\/10.1002\/cncr.22991","journal-title":"Cancer"},{"key":"5852_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jbo.2018.09.007","volume":"13","author":"T Wisanuyotin","year":"2018","unstructured":"Wisanuyotin T, Sirichativapee W, Sumnanoont C, Paholpak P, Laupattarakasem P, Sukhonthamarn K et al (2018) Prognostic and risk factors in patients with metastatic bone disease of an upper extremity. J Bone Oncol 13:71\u201375. https:\/\/doi.org\/10.1016\/j.jbo.2018.09.007","journal-title":"J Bone Oncol"},{"key":"5852_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1186\/s12885-023-11292-5","volume":"23","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wang J, Wu H, Lin Y, Chekhonin VP, Peltzer K et al (2023) Ten-year retrospect of the investigation of proximal limbs metastasis in cancer: a multi-center study on survival outcome, limb function status and surgical procedures analysis. BMC Cancer 23:795. https:\/\/doi.org\/10.1186\/s12885-023-11292-5","journal-title":"BMC Cancer"},{"issue":"1","key":"5852_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13018-023-03620-z","volume":"18","author":"J W\u00e4nman","year":"2023","unstructured":"W\u00e4nman J, Kjartansd\u00f3ttir S, Wolf O, Sundkvist J, Wennergren D, Mukka S (2023) Age, sex, primary tumor type and site are associated with mortality after pathological fractures: an observational study of 1453 patients from the Swedish fracture register. J Orthop Surg Res 18(1):150. https:\/\/doi.org\/10.1186\/s13018-023-03620-z","journal-title":"J Orthop Surg Res"},{"key":"5852_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","volume":"9","author":"RE Coleman","year":"2004","unstructured":"Coleman RE, Bisphosphonates (2004) Clin Experience Oncologist 9:14\u201327. https:\/\/doi.org\/10.1634\/theoncologist.9-90004-14","journal-title":"Clin Experience Oncologist"},{"key":"5852_CR22","unstructured":"Time of survival (2024) and quality of life of the patients operatively treated due to pathological fractures due to bone metastases - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/18034018\/"},{"key":"5852_CR23","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.ccr-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s\u20136249. https:\/\/doi.org\/10.1158\/1078-0432.ccr-06-0931. s","journal-title":"Clin Cancer Res"},{"key":"5852_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Cl\u00e9zardin","year":"2021","unstructured":"Cl\u00e9zardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F et al (2021) Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev 101:797\u2013855. https:\/\/doi.org\/10.1152\/physrev.00012.2019","journal-title":"Physiol Rev"},{"key":"5852_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s00774-023-01424-z","volume":"41","author":"H Taipaleenm\u00e4ki","year":"2023","unstructured":"Taipaleenm\u00e4ki H (2023) Secreted MicroRNAs in bone metastasis. J Bone Min Metab 41:358\u2013364. https:\/\/doi.org\/10.1007\/s00774-023-01424-z","journal-title":"J Bone Min Metab"},{"key":"5852_CR26","doi-asserted-by":"publisher","first-page":"100272","DOI":"10.1016\/j.bonr.2020.100272","volume":"12","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, Tang E-T, Li C, Zhu L, Zhang B, Glennane T et al (2020) What is the relationship between bone turnover markers and skeletal-related events in patients with bone metastases from solid tumors and in patients with multiple myeloma? A systematic review and meta-regression analysis. Bone Rep 12:100272. https:\/\/doi.org\/10.1016\/j.bonr.2020.100272","journal-title":"Bone Rep"},{"key":"5852_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/medicina57090967","volume":"57","author":"T-H Chiu","year":"2021","unstructured":"Chiu T-H, Lin C-Y, Hsieh M-H, Lin S-M, Fang Y-F (2021) Prognostic factors in lung adenocarcinoma with bone metastasis treated with EGFR-TKIs. Med (Kaunas) 57:967. https:\/\/doi.org\/10.3390\/medicina57090967","journal-title":"Med (Kaunas)"},{"key":"5852_CR28","doi-asserted-by":"publisher","first-page":"CD003474","DOI":"10.1002\/14651858.CD003474.pub4","volume":"10","author":"B O\u2019Carrigan","year":"2017","unstructured":"O\u2019Carrigan B, Wong MH, Willson ML, Stockler MR, Pavlakis N, Goodwin A (2017) Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev 10:CD003474\u2013CD003474. https:\/\/doi.org\/10.1002\/14651858.CD003474.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"5852_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/pcan.2016.26","volume":"19","author":"LE Howard","year":"2016","unstructured":"Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR et al (2016) Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer? Prostate Cancer Prostatic Dis 19:380\u2013384. https:\/\/doi.org\/10.1038\/pcan.2016.26","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5852_CR30","doi-asserted-by":"publisher","first-page":"e12541","DOI":"10.1111\/ecc.12541","volume":"26","author":"GZ Zheng","year":"2016","unstructured":"Zheng GZ, Chang B, Lin FX, Xie D, Hu QX, Yu GY et al (2016) Meta-analysis comparing denosumab and Zoledronic acid for treatment of bone metastases in patients with advanced solid tumours. Eur J Cancer Care (Engl) 26:e12541. https:\/\/doi.org\/10.1111\/ecc.12541","journal-title":"Eur J Cancer Care (Engl)"},{"key":"5852_CR31","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/s1470-2045(14)70183-4","volume":"15","author":"O Sartor","year":"2014","unstructured":"Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O\u2019Sullivan JM et al (2014) Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. Lancet Oncol 15:738\u2013746. https:\/\/doi.org\/10.1016\/s1470-2045(14)70183-4","journal-title":"Lancet Oncol"},{"key":"5852_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00003086-198309000-00041","volume":"178","author":"BJ GAINOR","year":"1983","unstructured":"GAINOR BJ (1983) Fracture healing in metastatic bone disease. Clin Orthop Relat Res 178:297\u2013302. https:\/\/doi.org\/10.1097\/00003086-198309000-00041","journal-title":"Clin Orthop Relat Res"}],"container-title":["Archives of Orthopaedic and Trauma Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-025-05852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00402-025-05852-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-025-05852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:20:55Z","timestamp":1767169255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00402-025-05852-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5852"],"URL":"https:\/\/doi.org\/10.1007\/s00402-025-05852-6","relation":{},"ISSN":["1434-3916"],"issn-type":[{"value":"1434-3916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"253"}}